<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Date: 2013-12-06 12:12:15Technology Premarket approval Center for Devices and Radiological Health Medical device Federal Food Drug and Cosmetic Act Title 21 of the Code of Federal Regulations Adverse event Investigational Device Exemption Unique Device Identification Food and Drug Administration Medicine Health |
Add to Reading List |
P080029 Quick-Close® Vascular Suturing System | Print Form Alabama Board of Medical Examiners P.O. Box 946, Montgomery, ALOffice-Based Surgery Adverse Event Report FormDocID: 1vm7X - View Document |
| Washington University in St. Louis Institutional Biological & Chemical Safety Committee Policy on Severe Adverse Event Reporting for Human Gene Therapy Trials As outlined in Section IV-B-2-b-(1) of the NIH Guidelines forDocID: 1vily - View Document |
| National Action Plan for Adverse Drug Event PreventionDocID: 1v1KN - View Document |
| Microsoft Word - FINAL-Formatted-University Adverse Weather and Emergency Event Policy -effDocID: 1uZd2 - View Document |
| National Action Plan for Adverse Drug Event PreventionDocID: 1uxaR - View Document |